Five fluorocarbons for administration of aerosol bronchodilators.
The exposure of the upper respiratory tract to aerosol propellants produces apnea, bradycardia, and biphasic fall and rise in aortic blood pressure in anesthetized dogs. This response represents the irritation of sensory receptors in the nasal and nasopharyngeal mucosa and is not elicited with aerosol propellants administered via a tracheal cannula bypassing the upper respiratory tract. When this is done, a different reflex is elicited, consisting of tachycardia that is mediated by the thoracic sympathetic nerves. There is either bronchodilation or bronchoconstriction depending on the type of propellant. The three propellants (11, 12, and 114) widely used in aerosols, when inspired in large doses, elicit both bradycardia and tachycardia and induce bronchoconstriction or bronchodilation. Two additional propellants (115 and C318), which are not ordinarily used to dispense bronchodilator drugs, do not elicit any change in heart rate and produce only bronchodilation. It is suggested that these two propellants merit further investigation and may replace the three widely used ones if these prove the use and abuse of aerosols.
D000335:Aerosol Propellants; D000758:Anesthesia; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004285:Dogs; D004569:Electroencephalography; D004837:Epinephrine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage*; D008168:Lung / Q000187:drug effects; D008170:Lung Compliance / Q000187:drug effects; D011312:Pressure; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014690:Venous Pressure / Q000187:drug effects
D000335:Aerosol Propellants; D001993:Bronchodilator Agents; D006845:Hydrocarbons, Fluorinated; D004837:Epinephrine